162 related articles for article (PubMed ID: 8336750)
1. An association between the risk of cancer and mutations in the HRAS1 minisatellite locus.
Krontiris TG; Devlin B; Karp DD; Robert NJ; Risch N
N Engl J Med; 1993 Aug; 329(8):517-23. PubMed ID: 8336750
[TBL] [Abstract][Full Text] [Related]
2. Genetic susceptibility associated with rare HRAS1 variable number of tandem repeats alleles in Spanish non-small cell lung cancer patients.
Rosell R; Calvo R; Sánchez JJ; Maurel J; Guillot M; Monzó M; Núñez L; Barnadas A
Clin Cancer Res; 1999 Jul; 5(7):1849-54. PubMed ID: 10430091
[TBL] [Abstract][Full Text] [Related]
3. Rare HRAS1 alleles are a risk factor for the development of brain tumors.
Vega A; Sobrido MJ; Ruiz-Ponte C; Barros F; Carracedo A
Cancer; 2001 Dec; 92(11):2920-6. PubMed ID: 11753967
[TBL] [Abstract][Full Text] [Related]
4. The HRAS1 variable number of tandem repeats and risk of breast cancer.
Tamimi RM; Hankinson SE; Ding S; Gagalang V; Larson GP; Spiegelman D; Colditz GA; Krontiris TG; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1528-30. PubMed ID: 14693748
[TBL] [Abstract][Full Text] [Related]
5. Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus.
Phelan CM; Rebbeck TR; Weber BL; Devilee P; Ruttledge MH; Lynch HT; Lenoir GM; Stratton MR; Easton DF; Ponder BA; Cannon-Albright L; Larsson C; Goldgar DE; Narod SA
Nat Genet; 1996 Mar; 12(3):309-11. PubMed ID: 8589723
[TBL] [Abstract][Full Text] [Related]
6. Specific H-Ras minisatellite alleles in breast cancer susceptibility.
Gosse-Brun S; Sauvaigo S; Daver A; Page M; Lortholary A; Larra F; Bignon YJ; Bernard-Gallon D
Anticancer Res; 1999; 19(6B):5191-6. PubMed ID: 10697533
[TBL] [Abstract][Full Text] [Related]
7. The HRAS1 minisatellite locus and risk of ovarian cancer.
Weitzel JN; Ding S; Larson GP; Nelson RA; Goodman A; Grendys EC; Ball HG; Krontiris TG
Cancer Res; 2000 Jan; 60(2):259-61. PubMed ID: 10667571
[TBL] [Abstract][Full Text] [Related]
8. Association between H-ras minisatellite and colorectal cancer risk.
Gosse-Brun S; Sauvaigo S; Daver A; Larra F; Kwiatkowski F; Bignon YJ; Bernard-Gallon D
Anticancer Res; 1998; 18(4A):2611-6. PubMed ID: 9703917
[TBL] [Abstract][Full Text] [Related]
9. Current evidence on the relationship between HRAS1 polymorphism and breast cancer risk: a meta-analysis.
Zhang C; Lv GQ; Yu XM; Gu YL; Li JP; Du LF; Zhou P
Breast Cancer Res Treat; 2011 Jul; 128(2):467-72. PubMed ID: 21221763
[TBL] [Abstract][Full Text] [Related]
10. Hras1 VNTR alleles as susceptibility markers for lung cancer: relationship to microsatellite instability in tumors.
Lindstedt BA; Ryberg D; Zienolddiny S; Khan H; Haugen A
Anticancer Res; 1999; 19(6C):5523-7. PubMed ID: 10697610
[TBL] [Abstract][Full Text] [Related]
11. Short rare MUC6 minisatellites-5 alleles influence susceptibility to gastric carcinoma by regulating gene.
Kwon JA; Lee SY; Ahn EK; Seol SY; Kim MC; Kim SJ; Kim SI; Chu IS; Leem SH
Hum Mutat; 2010 Aug; 31(8):942-9. PubMed ID: 20506113
[TBL] [Abstract][Full Text] [Related]
12. [Allelotyping the Hras1 minisatellite: formation of carcinogenic risk groups and predicting the course of non-small cell lung cancer].
Chizhikov VV; Gaspar'ian AV; Zborovskaia IB
Genetika; 2001 Oct; 37(10):1388-95. PubMed ID: 11761616
[TBL] [Abstract][Full Text] [Related]
13. A hereditary genetic marker closely associated with microsatellite instability in lung cancer.
Ryberg D; Lindstedt BA; Zienolddiny S; Haugen A
Cancer Res; 1995 Sep; 55(18):3996-9. PubMed ID: 7664270
[TBL] [Abstract][Full Text] [Related]
14. HRAS1 minisatellite alleles in colorectal carcinoma: relationship to microsatelite instability.
Vega A; Barros F; Lleonart ME; Ramon y Cajal S; Carracedo A
Anticancer Res; 2001; 21(4A):2855-60. PubMed ID: 11724366
[TBL] [Abstract][Full Text] [Related]
15. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
16. BRCA1 mutations and prostate cancer in Poland.
Cybulski C; Górski B; Gronwald J; Huzarski T; Byrski T; Debniak T; Jakubowska A; Wokołorczyk D; Gliniewicz B; Sikorski A; Stawicka M; Godlewski D; Kwias Z; Antczak A; Krajka K; Lauer W; Sosnowski M; Sikorska-Radek P; Bar K; Klijer R; Romuald Z; Małkiewicz B; Borkowski A; Borkowski T; Szwiec M; Posmyk M; Narod SA; Lubiński J
Eur J Cancer Prev; 2008 Feb; 17(1):62-6. PubMed ID: 18090912
[TBL] [Abstract][Full Text] [Related]
17. [Increased risk of occurrence of pulmonary adenocarcinoma in man is associated with the presence of rare alleles of the Hras1 minisatellite].
Gaspar'ian AV; Zborovskaia IB; Mukeriia AF; Tatosian AG; Zaridze DG
Genetika; 1998 Nov; 34(11):1537-41. PubMed ID: 10096029
[TBL] [Abstract][Full Text] [Related]
18. Debrisoquine hydroxylase (CYP2D6) and prostate cancer.
Febbo PG; Kantoff PW; Giovannucci E; Brown M; Chang G; Hennekens CH; Stampfer M
Cancer Epidemiol Biomarkers Prev; 1998 Dec; 7(12):1075-8. PubMed ID: 9865424
[TBL] [Abstract][Full Text] [Related]
19. [Study of HRas1 minisatellite frequencies in children with thyroid papillary cancer].
Iarmolinskiĭ DG; Kartel NA; Ermak G; Demidchik IuE; Figge J
Tsitol Genet; 2004; 38(1):9-14. PubMed ID: 15098441
[TBL] [Abstract][Full Text] [Related]
20. TGFBR1*6A and cancer risk: a meta-analysis of seven case-control studies.
Kaklamani VG; Hou N; Bian Y; Reich J; Offit K; Michel LS; Rubinstein WS; Rademaker A; Pasche B
J Clin Oncol; 2003 Sep; 21(17):3236-43. PubMed ID: 12947057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]